Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.
Financial Results:
Torrent Pharmaceuticals Ltd reported Revenues for Q3FY24 of ₹2,732.00 Crores up from ₹2,491.00 Crore year on year, a rise of 9.67%.
Total Expenses for Q3FY24 of ₹2,156.00 Crores up from ₹2,062.00 Crores year on year, a rise of 4.56%.
Consolidated Net Profit of ₹443.00 Crores up 51.71% from ₹292.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹13.09, up 51.68% from ₹8.63 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.